Literature DB >> 8089695

Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus.

M F Cordeiro, M E Lloyd, D J Spalton, G R Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8089695      PMCID： PMC1073153          DOI： 10.1136/jnnp.57.9.1142

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  8 in total

1.  Subungual splinter haemorrhages: a new sign of the antiphospholipid coagulopathy?

Authors:  R A Asherson
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

2.  Optic neuritis and myelopathy in systemic lupus erythematosus.

Authors:  S Oppenheimer; B I Hoffbrand
Journal:  Can J Neurol Sci       Date:  1986-05       Impact factor: 2.104

3.  Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome.

Authors:  R A Asherson; P Merry; J F Acheson; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

4.  Cerebrovascular ischemia associated with lupus anticoagulant.

Authors:  S R Levine; K M Welch
Journal:  Stroke       Date:  1987 Jan-Feb       Impact factor: 7.914

5.  Increased immunoglobulin binding to cerebral endothelium in patients with antiphospholipid antibodies.

Authors:  D C Hess; J C Sheppard; R J Adams
Journal:  Stroke       Date:  1993-07       Impact factor: 7.914

6.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

Authors:  R W Beck; P A Cleary; M M Anderson; J L Keltner; W T Shults; D I Kaufman; E G Buckley; J J Corbett; M J Kupersmith; N R Miller
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

7.  Unusual eye manifestations in systemic lupus erythematosus patients.

Authors:  A A Drosos; C A Petris; G M Petroutsos; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

8.  Ocular thrombosis associated with antiphospholipid antibodies.

Authors:  S L Galetta; G L Plock; M J Kushner; R E Wyszynski; A J Brucker
Journal:  Ann Ophthalmol       Date:  1991-06
  8 in total
  4 in total

Review 1.  Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature.

Authors:  B Kovacs; T L Lafferty; L H Brent; R J DeHoratius
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

2.  Recurrent and Reversible, Bitemporal Field Defect from Presumed Chiasmitis in a Patient with Systemic Lupus Erythematosus.

Authors:  Glauco Batista Almeida; Nilson Moro; Mário Luiz Ribeiro Monteiro
Journal:  Neuroophthalmology       Date:  2020-07-16

Review 3.  Demyelination in rheumatic diseases.

Authors:  A Theodoridou; L Settas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

4.  Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature.

Authors:  Mohammad Adawi; Bishara Bisharat; Abdalla Bowirrat
Journal:  Clin Med Insights Case Rep       Date:  2014-06-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.